Kezar Life Sciences, Inc. (KZR)
NASDAQ: KZR · Real-Time Price · USD
7.55
+0.06 (0.80%)
Nov 21, 2024, 12:28 PM EST - Market open
Kezar Life Sciences Employees
Kezar Life Sciences had 58 employees as of December 31, 2023. The number of employees decreased by 26 or -30.95% compared to the previous year.
Employees
58
Change (1Y)
-26
Growth (1Y)
-30.95%
Revenue / Employee
n/a
Profits / Employee
-$1,651,345
Market Cap
55.09M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Prenetics Global | 324 |
Singular Genomics Systems | 255 |
Vor Biopharma | 168 |
Enzo Biochem | 136 |
Vicarious Surgical | 131 |
Aadi Bioscience | 89 |
Shattuck Labs | 75 |
Immuneering | 68 |
KZR News
- 8 days ago - Kezar Life Sciences Reports Third Quarter 2024 Financial Results and Provides Business Update - Business Wire
- 16 days ago - Glancy Prongay & Murray LLP Announces Investigation of Kezar Life Sciences, Inc. (KZR) - Business Wire
- 24 days ago - Kezar Life Sciences Announces 1-for-10 Reverse Stock Split - Business Wire
- 5 weeks ago - Kezar Board Unanimously Rejects Unsolicited Concentra Proposal and Adopts Limited Duration Stockholder Rights Plan - Business Wire
- 5 weeks ago - Kezar Life Sciences Announces Positive IDMC Safety Review of PORTOLA Trial of Zetomipzomib in Patients with Autoimmune Hepatitis and Provides PALIZADE Update - Business Wire
- 6 weeks ago - Kezar Confirms Receipt of Unsolicited, Non-Binding Acquisition Proposal - Business Wire
- 6 weeks ago - US FDA puts clinical hold on Kezar Life Sciences' lupus treatment trial - Reuters
- 6 weeks ago - Kezar Life Sciences Announces Clinical Hold of Zetomipzomib IND for Treatment of Lupus Nephritis - Business Wire